Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thyme plus standard triple therapy for Helicobacter pylori eradication versus standard regimen alone
IRCT2015102024625N1Phase 3Completed
- Sponsor
- Vice-Chancellor for Research, Semnan University of Medical Sciences
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of thyme in Helicobacter pylori infection (2 arms), sponsored by Vice-Chancellor for Research, Semnan University of Medical Sciences. Primary endpoint: Helicobacter pylori eradication rate. Started Aug 2015; status: completed.
02
Drugs
thyme
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT2015102024625N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015102024625N1.